We must work to prevent and prepare for other pandemics while fighting against COVID-19

DUBAI, 1 February 2022 – Global experts have stressed the urgent need for the international community to collaborate in preparedness and prevention against new pandemics, particularly in regard to protecting vulnerable populations.

‘The Next Wave | Preventing and Preparing to Beat Future Pandemics’ event – held in association with the World Health Organization (WHO) and the Mohammed bin Rashid University of Medicine and Health Sciences

Speakers at the hybrid ‘The Next Wave | Preventing and Preparing to Beat Future Pandemics’ event – held in association with the World Health Organization (WHO) and the Mohammed bin Rashid University of Medicine and Health Sciences as part of Expo 2020 Dubai’s Health and Wellness Week – underscored that the fight against COVID-19 must continue as long as people remain without access to vaccinations – a figure that currently amounts to roughly three billion people, mostly in low-income countries.

Dr Seth Berkley, CEO at Gavi, the Vaccine Alliance, which is a co-lead on COVAX, a global initiative aimed at equitable access to COVID-19 vaccines, delivering more than 1 billion doses in less than a year, said: “COVAX has proven that it can deliver, but we faced obstacles including a lack of early at-risk funding, vaccine awarding, export restrictions and scaling up of manufacturing, which led to delays in equitable access that we cannot afford.”

Dr Berkley urged leaders from public and private sectors to renew their support and help raise the minimum needed USD 5.2 billion in additional funds over the next three months as part of an initiative titled the Gavi COVAX AMC 2022 Investment Opportunity. “This [investment] will help COVAX create a pandemic vaccine pool, a buffer to protect its supply in case of future bottlenecks, and meet the emerging needs of countries, which is ultimately what it will take to stifle this virus,” he said.

Dr Seth Berkley, CEO at Gavi, the Vaccine Alliance, which is a co-lead on COVAX, a global initiative aimed at equitable access to COVID-19 vaccines

Dr Rhoda Wanyenze, Professor and Dean, School of Public Health, Makerere University, spoke about the effects of measures to limit the spread of COVID-19 in Africa, and specifically Uganda, the Democratic Republic of Congo, Nigeria and Senegal. Such measures often restricted access to food, water and education in vulnerable communities, and hampered access to healthcare services for other diseases, which led to Ebola and polio outbreaks.

Dr Donald Kaberuka, Chair, The Global Fund Board, said: “We cannot separate old and new pandemics, but instead need a package that handles all of them together… We have to invest in dealing with COVID because it is a danger to [progress on] other pandemics, which have been killing many more people than COVID itself, like AIDS and malaria. These are largely a problem in the Global South rather than wealthy countries, and therefore the attention and bandwidth is narrower – and this is a huge risk for the achievements of the last 25 years.”

Discussing zoonotic diseases that are at the root of many pandemics, Dr Neil Vora, pandemic prevention fellow, Conservation International, argued that pandemic prevention – such as combatting deforestation to reduce human wildlife interaction and regulating wildlife trade and markets – is far more economical and effective. “If implemented properly, pandemic prevention activities would cost USD 10-20 billion annually, compared to the millions of lives and trillions of dollars lost from a pandemic such as COVID,” said Dr Vora.

Moreover, Professor Andrew Cunningham, Deputy Director of Science, Institute of Zoology, Zoological Society of London, highlighted that the drivers of zoonotic disease emergence are also the force behind biodiversity loss and climate change, meaning that investing in pandemic prevention could address several global challenges at once.

The drivers of zoonotic disease emergence are also the force behind biodiversity loss and climate change, meaning that investing in pandemic prevention could address several global challenges at once.

Health and Wellness Week is one of 10 Theme Weeks held under Expo 2020’s Programme for People and Planet, offering an exchange of inspiring new perspectives to address the greatest challenges and opportunities of our time.

ameerul.hasan@thechangemakers.news

Kinnos crowned winner of Arab Health Innov8 competition

Dubai, United Arab Emirates, 27 January 2022: Kinnos, an infection prevention company pioneering colourised disinfection, has won this years’ Arab Health Innov8 competition, following an intensive week-long judging process that saw a total of 24 different companies pitch over the opening three days of Arab Health, culminating in today’s grand finale.

Kinnos, an infection prevention company pioneering colourised disinfection, has won this years’ Arab Health Innov8 competition

Finalists included UniExo Rehab from Ukraine, who have developed a wearable modular robotic exoskeleton device that helps improve rehab for all limbs; Healthcare X.0 GmbH, a German-based company that has developed a unique software program to package patient data into a digital patient file with a focus on the fight against cancer, and winner, New York-based Kinnos.

Kinnos’ patented Highlight technology standardises disinfection techniques and leads to better metrics. Highlight is the only product on the market designed to provide real-time visual feedback during manual disinfection so that quality is maintained every single time a disinfectant is used.

Jason Kang, CEO, Kinnos, said: “Effective infection prevention requires not just the disinfectant, but also technique in how those disinfectants are used. Yet the status quo makes it virtually impossible to ensure thorough disinfection as it’s currently an invisible process – with transparent disinfectants, you can’t see what you’ve missed. We’re making that easier in a way that transcends language barriers.

Jason Kang, CEO, Kinnos, said: “Effective infection prevention requires not just the disinfectant, but also technique in how those disinfectants are used.

“Moving forward, consumers are expecting enhanced disinfection measures; Highlight is a very intuitive, tangible and visible way for businesses and organisations to show their commitment to safety and provide that better patient experience.”

Highlight works by colouring the liquid bleach and disinfecting wipes that hospitals depend on to clean surfaces, letting users visualise disinfection coverage instantly. The colour lends visibility, reinforces training, and fades to remind users that their disinfectant is still working. In more than one critical healthcare situation, it prevented the use of incorrectly mixed or expired bleach products since its colour fades only if healthcare-strength bleach is utilised.

The judging panel included a renowned number of investors, entrepreneurs and medical experts; among them were Andreea Danila, Founder & General Partner, Global Millennial Capital; Sajjad Kamal, Partner – Healthtech, Global Ventures; and Dirk Richter, Director Health Sector Innovation, Department of Health, Abu Dhabi.

As the winner, Kinnos will receive a complimentary exhibition stand space at Arab Health 2023 and a three-month mentorship programme by Andreea Danila, award-winning entrepreneur and venture capitalist.

Ross Williams, Exhibition Director for Informa Markets, said: “We’d like to congratulate the innovative team behind Kinnos; they have delivered an outstanding product that will undoubtedly support the healthcare industry moving forward, and particularly against the challenges of COVID-19.

Ross Williams, Exhibition Director for Informa Markets, said: “We’d like to congratulate the innovative team behind Kinnos; they have delivered an outstanding product that will undoubtedly support the healthcare industry moving forward, and particularly against the challenges of COVID-19. This is another prime example of the healthcare industry coming together and developing cutting-edge technology to solve a potentially substantial health problem.”

Arab Health and Medlab Middle East conclude today, Thursday 27 January, at 5pm.

ameerul.hasan@thechangemakers.news

London’s King’s College Hospital to open its doors in Jeddah

Building on the success of King’s College Hospital Dubai, which in a short period of time has become one of the best hospitals in UAE, Ashmore Group, a specialist emerging markets investment manager, in partnership with King’s College Hospital London and Saudi Bugshan Group, is pleased to announce the start of construction of King’s College Hospital Jeddah (“KCHJ”). The hospital is scheduled to open its doors to patients in the second half of 2023, and this is expected to be the first of many similar projects providing Ashmore and King’s the platform for further growth in KSA.

Jeddah, in the Kingdom of Saudi Arabia, is set to become home to a 150-bed world-class multi-speciality hospital, which will be fully integrated with King’s College Hospital’s facilities in London.

KCHJ will be the country’s first truly integrated hospital bringing the full benefits of King’s College Hospital London to KSA, and playing its role in achieving the Kingdom’s 2030 vision in the healthcare sector. The London-based tertiary hospital is part of the world leading UK National Health Service, with a 180 year history of successfully caring for patients with complex conditions. King’s is also one of the largest teaching hospitals in the UK. The hospital’s 13,000+ staff in London treat over one million patients every year.

Scheduled to open in 2023, the state-of-the-art King’s College Hospital Jeddah, located on King Abdulaziz Road, will cover an area of over 32000 square meters, with a capacity of 150 beds in the first phase. The hospital will be staffed with over 1000 leading healthcare professionals, sourced from London, KSA and wider region, delivering care in line with the tested clinical pathways of King’s College Hospital London.

Clinical innovation and smart technologies will be a prominent feature at the hospital, with 40 medical and surgical specialties and four Centres of Excellence in the following Institutes: Women’s Health, Metabolic Diseases & Bariatric Surgery, Orthopaedics and Heart & Vascular. The patient-centred care model, staffing and services will all be fully integrated with King’s College Hospital London, designed to address a range of complex and critical care requirements unique to the residents and communities of the Kingdom of Saudi Arabia.

Scheduled to open in 2023, the state-of-the-art King’s College Hospital Jeddah, located on King Abdulaziz Road, will cover an area of over 32000 square meters, with a capacity of 150 beds in the first phase.

Ahsan Ali, Head of Healthcare Private Equity at Ashmore commented: “We stand true to our ambition and commitment to bringing the best of British healthcare to the region in partnership with King’s College Hospital London. Following the success of King’s hospital and clinics in Dubai, entering Saudi Arabia marks a new chapter for King’s and Ashmore, with the first project being a landmark hospital in Jeddah. We expect to follow this with the establishment of similar King’s branded facilities, including specialized centres, in other parts of the Kingdom.”

The London and Jeddah hospitals will share knowledge from established King’s research centres in the UK. Utilizing King’s world-leading expertise in healthcare will ensure the very best quality of evidence-based care is accessible to patients in Jeddah, will encourage further collaborations between physicians in both countries, and enable seamless patient journeys between the Jeddah and London hospitals, reducing the need for patients to travel to the UK.

Sir Hugh Taylor, Chairman of King’s College Hospital, London said, ‘’We are delighted that King’s, in partnership with Ashmore, is expanding its footprint to Saudi Arabia, following on from the success of our hospital and clinics in the UAE. King’s College Hospital has a long history of providing outstanding patient care in London and as part of our “Strong roots, Global reach” strategy we remain committed to delivering outstanding care for patients in Saudi Arabia”

Mark Coombs, Chief Executive Officer of Ashmore Group plc, added, “Ashmore Group remains committed to supporting KSA’s continued development across multiple areas. We have been active in KSA over the last two decades and were the first international fund manager to establish local operations1 with a dedicated team in Riyadh, and we are now excited about playing our role in the development of KSA’s healthcare sector by bringing King’s to the country.”

The London and Jeddah hospitals will share knowledge from established King’s research centres in the UK.

UK Government’s Department for International Trade (DIT) has been supporting Ashmore and King’s College Hospital with this project in Jeddah and added “The proposed Jeddah development will greatly benefit from having an NHS partner – King’s College Hospital – which will support the Kingdom’s Healthcare transformation and allow for valuable expertise and knowledge transfer to help shape the healthcare provision. This will be the first hospital in The Kingdom to partner with the National Health Service”.

ameerul.hasan@thechangemakers.news